Page last updated: 2024-11-07

saikosaponin d

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Saikosaponin d is a triterpenoid saponin found in the roots of the Bupleurum plant. It exhibits a range of pharmacological activities including anti-inflammatory, hepatoprotective, neuroprotective, and anticancer properties. Its complex structure makes it a challenging compound to synthesize, requiring multiple steps and intricate chemical transformations. The potential therapeutic applications of saikosaponin d have spurred significant research interest, especially in the development of treatments for liver disease, inflammation, and neurodegenerative conditions. Studies have investigated its mechanism of action, focusing on its ability to modulate various signaling pathways and interact with specific cellular targets. While its exact mechanisms are still being elucidated, saikosaponin d holds promise as a potential therapeutic agent for a variety of ailments.'

Cross-References

ID SourceID
PubMed CID107793
CHEMBL ID3613719
SCHEMBL ID929710
MeSH IDM0085526

Synonyms (23)

Synonym
saikosaponins
beta-d-galactopyranoside, (3beta,4alpha,16alpha)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl 6-deoxy-3-o-beta-d-glucopyranosyl-
saikosaponin d
(2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-3,5-dihydroxy-2-[hydroxy-(hydroxymethyl)-hexamethyl-[?]yl]oxy-6-methyl-tetrahydropyran-4-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
beta-d-galactopyranoside, (3beta,4alpha,16alpha)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl 6-deoxy-3-o-beta-d-glucopyranosyl
20874-52-6
AKOS016034270
unii-ur635j3f00
ur635j3f00 ,
S5454
.beta.-d-galactopyranoside, (3.beta.,4.alpha.,16.alpha.)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl 6-deoxy-3-o-.beta.-d-glucopyranosyl-
SCHEMBL929710
Q-100262
CHEMBL3613719
saikosaponin d from bupleurum falcatnum
mfcd09028095
CS-0008281
HY-N0250
KYWSCMDFVARMPN-LCSVLAELSA-N
CCG-270465
Q27291219
(2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-3,5-dihydroxy-2-[[(1s,2r,4s,5r,8r,9r,10s,13s,14r,17s,18r)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracos-15-en-10-yl]oxy]-6-methyloxan-4-yl]oxy-6-(hydroxym
DTXSID301317467

Research Excerpts

Overview

Saikosaponin D (SSD) is a triterpenoid saponin with many biological activities including anti-inflammatory effects and antioxidant properties. It provides protection against pathologic cardiac remodeling and fibrosis.

ExcerptReferenceRelevance
"Saikosaponin D (SSD), which is a triterpenoid saponin with many biological activities including anti-inflammatory effects and antioxidant properties, provides protection against pathologic cardiac remodeling and fibrosis."( Saikosaponin D Alleviates DOX-induced Cardiac Injury In Vivo and In Vitro.
Chen, XM; Cheng, YF; Jiang, W; Li, X; Luo, D; Pi, JK; Wang, XJ; Wang, XX; Wu, SS; Wu, Z; Xu, JY; Zhang, Y; Zhang, YJ; Zhou, JH, 2022
)
2.89
"Saikosaponin d (SSD) is a triterpenoid saponin isolated from Radix Bupleuri that has multiple pharmacological activities."( Saikosaponin d (SSD) alleviates diabetic peripheral neuropathy by regulating the AQP1/RhoA/ROCK signaling in streptozotocin-induced diabetic rats.
Chen, L; Liu, Y; Xiang, Q, 2023
)
3.07
"Saikosaponin D (SSD) is a triterpenoid saponin that has been reported to alleviate sepsis-triggered renal injury in mice."( Saikosaponin D attenuates inflammatory response and cell apoptosis of lipopolysaccharide-induced lung epithelial cells.
Lu, G; Song, L; Tao, Y, 2023
)
3.07
"Saikosaponin d (SSd) is a traditional Chinese medicine that has been widely used in depression treatment. "( Saikosaponin d downregulates microRNA-155 and upregulates FGF2 to improve depression-like behaviors in rats induced by unpredictable chronic mild stress by negatively regulating NF-κB.
Chao, B; Huang, S; Pan, J; Wang, Y; Zhang, Y, 2020
)
3.44
"Saikosaponin D (SSd) is a type of Saponin derivative, which is a component extracted from Bupleurum falactum. "( Effects of Saikosaponin D on apoptosis in human U87 glioblastoma cells.
Cai, T; Li, Y; Lv, S; Zhang, W; Zhu, W, 2017
)
2.29
"Saikosaponin D (SSD) is a major component of saikosaponins isolated from Bupleurum falactum, a herb that has been linked to hepatotoxicity."( Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity.
Chen, L; Chen, W; Kong, D; Wang, A; Zhang, F; Zheng, S; Zhu, X, 2013
)
2.55
"Saikosaponin D is an agonist of the glucocorticoid receptor (GR), and our preliminary study showed that it possesses neuroprotective effects in corticosterone-treated PC12 cells. "( Saikosaponin D acts against corticosterone-induced apoptosis via regulation of mitochondrial GR translocation and a GR-dependent pathway.
Guo, Z; Jiang, YM; Li, ZY; Liu, XM; Liu, YM; Pan, RL; Shen, SN, 2014
)
3.29
"Saikosaponin D (SSD) is a major component isolated from the medicinal herb Bupleurum falcatum, which has been linked to hepatotoxicity."( Activation of Fas death receptor pathway and Bid in hepatocytes is involved in saikosaponin D induction of hepatotoxicity.
Chen, L; Jin, H; Lu, Y; Shao, J; Wu, L; Zhang, F; Zheng, S, 2016
)
1.38
"Saikosaponin D is a saponin extract derived from several species of Bupleurum (Umbelliferae), which is used for the treatment of various liver diseases in traditional Chinese medicine. "( The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells.
Hsu, YL; Kuo, PL; Lin, CC, 2004
)
2.01

Effects

Saikosaponin D (SSd) has been reported to exhibit hepatoprotective and anti-steatosis activities. SSd has anti-inflammatory and induces autophagy effects via inhibiting the nuclear transcription factor-κB, mTOR signaling pathways.

ExcerptReferenceRelevance
"Saikosaponin D (SSd) has been reported to exhibit hepatoprotective and anti-steatosis activities in our previous research."( Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway.
Ding, M; Duan, S; Fan, G; Gu, Y; Li, X; Li, Y; Liu, C; Liu, R; Sun, R; Zheng, Q, 2022
)
2.89
"Saikosaponin D has anti-inflammatory and induces autophagy effects via inhibiting the nuclear transcription factor-κB, mTOR signaling pathways."( Saikosaponin D: A potential therapeutic drug for osteoarthritis.
Botchway, BOA; Hu, S; Jiang, J; Liu, X; Meng, Y; Zhang, Y, 2020
)
2.72

Treatment

ExcerptReferenceRelevance
"Treatment with saikosaponin d decreased the cell proliferation of Hep G2 and Hep 3B cells in a dose dependent manner."( Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines.
Chiang, LC; Hsu, YL; Kuo, PL; Lin, CC, 2004
)
0.87

Toxicity

ExcerptReferenceRelevance
" Our current study was to examine the toxic effect of SSD on human hepatocyte LO2 cells and explore the possible mechanism."( Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity.
Chen, L; Chen, W; Kong, D; Wang, A; Zhang, F; Zheng, S; Zhu, X, 2013
)
1.83
" Baking herb with vinegar is believed to attenuate the adverse responses."( Content decline of SERCA inhibitors saikosaponin a and d attenuates cardiotoxicity and hepatotoxicity of vinegar-baked Radix bupleuri.
Li, S; Peng, S; Qiao, Y; Shen, C; Wang, S; Wu, Q; Yang, W; Yu, Y; Zhang, M; Zhang, Q; Zhang, Y, 2017
)
0.46
" The current study provides experimental evidence for clinical safe use of RB, and also new insights into understanding the mechanism by which SS and RB induced liver injury."( Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study.
Huang, Y; Li, X; Liu, R; Lu, J; Luan, Y; Lv, L; Sun, R, 2017
)
0.46
" Saponins are the main pharmacodynamic and toxic components of Bupleuri Radix."( [Study on liver protection and hepatotoxicity of saikosaponin a based on zebrafish model].
Gao, JJ; Han, LW; He, QX; Liu, KC; Tu, PF; Xia, Q; Zhang, SS; Zhang, Y, 2019
)
0.51

Pharmacokinetics

ExcerptReferenceRelevance
" This quantitative measurement was successfully applied to a pharmacokinetic study of Yi-Qi-Fu-Mai injection."( An LC-MS method for simultaneous determination of nine ginsenosides in rat plasma and its application in pharmacokinetic study.
Lin, R; Tong, L; Wan, M; Wang, G; Wang, Z; Ye, Z; Zhou, D, 2011
)
0.37
" The validated method was successfully applied into a pharmacokinetic study of orally administered BDP in rats."( UFLC-MS/MS determination and pharmacokinetic studies of six Saikosaponins in rat plasma after oral administration of Bupleurum Dropping Pills.
Chu, Y; Guan, X; Li, S; Li, W; Liu, C; Ma, X; Sun, H; Wang, X; Yan, K; Yan, X; Zhou, S, 2016
)
0.43
" Pharmacokinetic tests were used to evaluate the effects of SSd on serum Dox disposition."( The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts.
Feng, LJ; Gai, XD; Li, C; Wang, ML; Wang, P; Xue, HG, 2017
)
0.82
" There was no significant difference between the Dox pharmacokinetic parameters obtained in the mice that received Dox only and Dox combined with SSd, indicating that SSd did not alter the pharmacokinetic profiles of Dox."( The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts.
Feng, LJ; Gai, XD; Li, C; Wang, ML; Wang, P; Xue, HG, 2017
)
0.82
" The concentration of the SSa in mice plasma and brain was determined by UPLC-MS/MS, and the pharmacokinetic parameters, bioavailability, the brain targeting coefficient (Re) and the brain drug targeting index (DTI) were calculated with Kinetica software."( [Comparison of different administration routes of saikosaponin in plasma pharmacokinetics and brain pharmacokinetics].
Chen, XL; Dai, YJ; Deng, XY; Tang, HY; Xie, L, 2017
)
0.46
" The validated LC-MS/MS method was successfully applied to the pharmacokinetic analysis of hesperidin, emodin, polydatin and naringin of SGZT in rat plasma after administration."( Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Guan, H; Han, H; Ju, Z; Li, G; Lin, J; Shi, M; Tang, J; Xu, Y; Zhang, T, 2021
)
0.62
" However, the pharmacokinetic (PK) behavior based on the combination of the two components has not been reported in rats."( Pharmacokinetic analysis for simultaneous quantification of Saikosaponin A- paeoniflorin in normal and poststroke depression rats: A comparative study.
Chen, Y; Han, X; Wan, H; Yang, J; Yin, P; Yu, L; Zhang, T; Zhou, H, 2023
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
"An efficient system to produce saikosaponins (saikosaponin-a and -d) in Bupleurum falcatum adventitious root fragments combined with signal transducers was developed."( Efficient production of saikosaponins in Bupleurum falcatum root fragments combined with signal transducers.
Aoyagi, H; Kobayashi, Y; Kusakari, K; Tanaka, H; Yamada, K; Yokoyama, M, 2001
)
0.31
"A method based on accelerated solvent extraction combined with rapid-resolution LC-MS for efficient extraction, rapid separation, online identification and accurate determination of the saikosaponins (SSs) in Radix bupleuri (RB) was developed."( Identification and determination of the saikosaponins in Radix bupleuri by accelerated solvent extraction combined with rapid-resolution LC-MS.
Chen, JX; Fan, CL; Guo, PR; Luo, HT; Tang, YZ; Yang, YY, 2010
)
0.36
"To observe the effects of interferon-alpha combined with saikosaponin on serum T lymphocyte subgroups and hepatic cytokines in mice with immune hepatic injury."( [Effects of interferon-alpha combined with saikosaponin on serum T lymphocyte subgroups and hepatic cytokines in mice with immune hepatic injury].
Chen, YY; Liu, GW; Xue, DY, 2012
)
0.38
"The aim of this study was to investigate the effects of Saikosaponin-d (SSd) combined with radiotherapy on SMMC-7721 hepatoma cell lines and its mechanism."( Effects of SSd combined with radiation on inhibiting SMMC-7721 hepatoma cell growth.
Bai, MH; Lin, S; Ma, HB; Min, WL; Song, LQ; Wang, BF; Wang, M; Wang, XJ; Yang, P, 2014
)
0.4
" Radiation caused ultrastructural damage to cells, and the damage was enhanced in combination with SSd."( Effects of SSd combined with radiation on inhibiting SMMC-7721 hepatoma cell growth.
Bai, MH; Lin, S; Ma, HB; Min, WL; Song, LQ; Wang, BF; Wang, M; Wang, XJ; Yang, P, 2014
)
0.4
" It also inhibited daclatasvir-resistant mutant strains of HCV, especially in combination with daclatasvir."( Antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus.
Hou, MC; Huang, YH; Lan, KH; Lan, KL; Lee, WP; Liao, SX, 2019
)
0.51
" Cell viability and wound healing assays demonstrated that SSd combined with NRP-1 knockdown could significantly enhance the damage of HepG2."( Untargeted Metabolomics Study of the In Vitro Anti-Hepatoma Effect of Saikosaponin d in Combination with NRP-1 Knockdown.
Chen, Y; Hou, X; Li, R; Lv, Y; Sun, R; Tian, Y; Xu, F; Xu, L; Zhang, Q; Zhang, Z, 2019
)
0.75
" A UHPLC system couple with a quadrupole combined with time of flight mass spectrometer was used for qualitatively analyzing of the composition of SGZT and its metabolites in serum, urine, bile and feces of rats."( Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Guan, H; Han, H; Ju, Z; Li, G; Lin, J; Shi, M; Tang, J; Xu, Y; Zhang, T, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
" A-44, are essential for the appearance of 2 and 3 in the rat plasma and cumulative feces, since orally administered 1 was poorly absorbed from the gastrointestinal tract."( Metabolism and pharmacokinetics of orally administered saikosaponin b1 in conventional, germ-free and Eubacterium sp. A-44-infected gnotobiote rats.
Akao, T; Hattori, M; Kida, H; Meselhy, MR, 1998
)
0.3
" However, the oral bioavailability of SGG was not obtained due to the extremely poor absorption in rats."( Pharmacokinetics and oral bioavailability studies of three saikogenins in rats using a validated UFLC-MS/MS method.
Fu, R; Liu, J; Ren, S; Song, R; Sun, J; Xue, Y; Zhang, Z, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
"Hepatic fibrosis models were induced by subcutaneous injection of CCl(4) at a dosage of 3 mL/kg in rats."( Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats.
Cheng, YA; Dang, SS; Li, ZF; Liu, ZG; Song, P; Wang, BF, 2007
)
0.34
" BLM group was similarly dosed with normal saline."( [Therapeutic effects and mechanism of saikosaponin-d in mice with bleomycin-induced pulmonary fibrosis].
Huang, ZJ; Lu, KQ; Tian, GR; Xia, DG; Zheng, JX, 2010
)
0.36
" Compared to the NTS control group, the middle dosage (10 mg/kg/day) of SSC significantly alleviated the development of nephritis based on urine protein measurements (34."( Utilizing methylglyoxal and D-lactate in urine to evaluate saikosaponin C treatment in mice with accelerated nephrotoxic serum nephritis.
Chen, BL; Chen, SM; Hua, SC; Lee, JA; Lee, TH; Lin, CE; Lin, CY; Lin, PY; Tsai, PY, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1244896Cytotoxicity against human HepG2 cells assessed as induction of cell death incubated for 2 days by MTT assay2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense.
AID1244898Cytotoxicity against human Bcap37 cells assessed as induction of cell death incubated for 2 days by MTT assay2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense.
AID1605078Inhibition of SERCA2 in C57BL/6 mouse primary neurons at 30 uM by UV-Vis spectrophotometric method relative to control2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
AID1605071Inhibition of SERCA (unknown origin)2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
AID1605077Inhibition of SERCA1 in C57BL/6 mouse primary neurons at 30 uM by UV-Vis spectrophotometric method relative to control2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
AID1244897Cytotoxicity against human Hep3B cells assessed as induction of cell death incubated for 2 days by MTT assay2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense.
AID1244899Cytotoxicity against human MCF7 cells assessed as induction of cell death incubated for 2 days by MTT assay2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense.
AID1605076Antiproliferative activity against human HeLa cells2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
AID1244895Cytotoxicity against human A549 cells assessed as induction of cell death incubated for 2 days by MTT assay2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (435)

TimeframeStudies, This Drug (%)All Drugs %
pre-199038 (8.74)18.7374
1990's48 (11.03)18.2507
2000's70 (16.09)29.6817
2010's176 (40.46)24.3611
2020's103 (23.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.91 (24.57)
Research Supply Index6.08 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index46.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.23%)5.53%
Reviews15 (3.43%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other421 (96.34%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]